Number of the records: 1
Discovery of tert-Butyl Ester Based 6-Diazo-5-oxo-L-norleucine Prodrugs for Enhanced Metabolic Stability and Tumor Delivery
- 1.
SYSNO 0578510 Title Discovery of tert-Butyl Ester Based 6-Diazo-5-oxo-L-norleucine Prodrugs for Enhanced Metabolic Stability and Tumor Delivery Author(s) Novotná, Kateřina (UOCHB-X) [390/39] ORCID
Tenora, Lukáš (UOCHB-X) [390/39] ORCID
Prchalová, E. (US)
Paule, J. (US)
Alt, J. (US)
Veeravalli, V. (US)
Lam, J. (US)
Wu, Y. (US)
Šnajdr, Ivan (UOCHB-X) [390/39] ORCID
Gori, S. (US)
Mettu, V. S. (US)
Tsukamoto, T. (US)
Majer, Pavel (UOCHB-X) [390/39]
Slusher, B. S. (US)
Rais, R. (US)Corespondence/senior Majer, Pavel - Korespondující autor
Slusher, B. S. - Korespondující autor
Rais, R. - Korespondující autorSource Title Journal of Medicinal Chemistry. Roč. 66, č. 22 (2023), s. 15493-15510. - : American Chemical Society Document Type Článek v odborném periodiku Grant LTAUSA18166 GA MŠMT - Ministry of Education, Youth and Sports (MEYS) LX22NPO5102 GA MŠMT - Ministry of Education, Youth and Sports (MEYS) Institutional support UOCHB-X - RVO:61388963 Language eng Country US Keywords phase-I * 6-diazo-5-oxo-l-norleucine DON * clinical pharmacology URL https://pubs.acs.org/doi/10.1021/acs.jmedchem.3c01681 Permanent Link https://hdl.handle.net/11104/0347498 File Download Size Commentary Version Access 10.1021acs.jmedchem.3c01681.pdf 0 2.8 MB Publisher’s postprint open-access
Number of the records: 1